Acebutolol-induced decrease of mononuclear leukocyte β-adrenoceptors in hypertension

A. Basso, L. Piantanelli, G. Cognini, S. Giunta, A. Andreoni, E. Paciaroni

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The regulatory action exerted on receptors by acebutolol, a cardioselective β-blocker containing intrinsic sympathomimetic activity, has been investigated. β-Adrenoceptor affinity and density of human mononuclear leukocytes were assayed in hypertensive patients before and after treatment with 400 mg/day acebutolol. While receptor affinity showed no changes between pre- and post-treatment values, a statistically significant decrease has been demonstrated in receptor density following treatment. Blood pressure and heart rate were also measured in order to test the efficacy of the administered drug. All these parameters showed a fall in the post-treatment values. It is concluded that the partial agonist acebutolol. in spite of the fact that it acts clinically as a β-blocker. has the regulatory mechanism characteristic of agonists.

Original languageEnglish
Pages (from-to)278-283
Number of pages6
JournalPharmacology
Volume31
Issue number5
DOIs
Publication statusPublished - 1985

Fingerprint

Acebutolol
Mononuclear Leukocytes
Adrenergic Receptors
Hypertension
Therapeutics
Sympathomimetics
Heart Rate
Blood Pressure
Pharmaceutical Preparations

Keywords

  • Acebutolol
  • Hypertension
  • Intrinsic sympathomimetic activity
  • Mononuclear leukocytes
  • β-Adrenoceptor regulation

ASJC Scopus subject areas

  • Pharmacology

Cite this

Basso, A., Piantanelli, L., Cognini, G., Giunta, S., Andreoni, A., & Paciaroni, E. (1985). Acebutolol-induced decrease of mononuclear leukocyte β-adrenoceptors in hypertension. Pharmacology, 31(5), 278-283. https://doi.org/10.1159/000138132

Acebutolol-induced decrease of mononuclear leukocyte β-adrenoceptors in hypertension. / Basso, A.; Piantanelli, L.; Cognini, G.; Giunta, S.; Andreoni, A.; Paciaroni, E.

In: Pharmacology, Vol. 31, No. 5, 1985, p. 278-283.

Research output: Contribution to journalArticle

Basso, A, Piantanelli, L, Cognini, G, Giunta, S, Andreoni, A & Paciaroni, E 1985, 'Acebutolol-induced decrease of mononuclear leukocyte β-adrenoceptors in hypertension', Pharmacology, vol. 31, no. 5, pp. 278-283. https://doi.org/10.1159/000138132
Basso, A. ; Piantanelli, L. ; Cognini, G. ; Giunta, S. ; Andreoni, A. ; Paciaroni, E. / Acebutolol-induced decrease of mononuclear leukocyte β-adrenoceptors in hypertension. In: Pharmacology. 1985 ; Vol. 31, No. 5. pp. 278-283.
@article{08276670116a461783aea7c9dac791a6,
title = "Acebutolol-induced decrease of mononuclear leukocyte β-adrenoceptors in hypertension",
abstract = "The regulatory action exerted on receptors by acebutolol, a cardioselective β-blocker containing intrinsic sympathomimetic activity, has been investigated. β-Adrenoceptor affinity and density of human mononuclear leukocytes were assayed in hypertensive patients before and after treatment with 400 mg/day acebutolol. While receptor affinity showed no changes between pre- and post-treatment values, a statistically significant decrease has been demonstrated in receptor density following treatment. Blood pressure and heart rate were also measured in order to test the efficacy of the administered drug. All these parameters showed a fall in the post-treatment values. It is concluded that the partial agonist acebutolol. in spite of the fact that it acts clinically as a β-blocker. has the regulatory mechanism characteristic of agonists.",
keywords = "Acebutolol, Hypertension, Intrinsic sympathomimetic activity, Mononuclear leukocytes, β-Adrenoceptor regulation",
author = "A. Basso and L. Piantanelli and G. Cognini and S. Giunta and A. Andreoni and E. Paciaroni",
year = "1985",
doi = "10.1159/000138132",
language = "English",
volume = "31",
pages = "278--283",
journal = "Pharmacology",
issn = "0031-7012",
publisher = "S. Karger AG",
number = "5",

}

TY - JOUR

T1 - Acebutolol-induced decrease of mononuclear leukocyte β-adrenoceptors in hypertension

AU - Basso, A.

AU - Piantanelli, L.

AU - Cognini, G.

AU - Giunta, S.

AU - Andreoni, A.

AU - Paciaroni, E.

PY - 1985

Y1 - 1985

N2 - The regulatory action exerted on receptors by acebutolol, a cardioselective β-blocker containing intrinsic sympathomimetic activity, has been investigated. β-Adrenoceptor affinity and density of human mononuclear leukocytes were assayed in hypertensive patients before and after treatment with 400 mg/day acebutolol. While receptor affinity showed no changes between pre- and post-treatment values, a statistically significant decrease has been demonstrated in receptor density following treatment. Blood pressure and heart rate were also measured in order to test the efficacy of the administered drug. All these parameters showed a fall in the post-treatment values. It is concluded that the partial agonist acebutolol. in spite of the fact that it acts clinically as a β-blocker. has the regulatory mechanism characteristic of agonists.

AB - The regulatory action exerted on receptors by acebutolol, a cardioselective β-blocker containing intrinsic sympathomimetic activity, has been investigated. β-Adrenoceptor affinity and density of human mononuclear leukocytes were assayed in hypertensive patients before and after treatment with 400 mg/day acebutolol. While receptor affinity showed no changes between pre- and post-treatment values, a statistically significant decrease has been demonstrated in receptor density following treatment. Blood pressure and heart rate were also measured in order to test the efficacy of the administered drug. All these parameters showed a fall in the post-treatment values. It is concluded that the partial agonist acebutolol. in spite of the fact that it acts clinically as a β-blocker. has the regulatory mechanism characteristic of agonists.

KW - Acebutolol

KW - Hypertension

KW - Intrinsic sympathomimetic activity

KW - Mononuclear leukocytes

KW - β-Adrenoceptor regulation

UR - http://www.scopus.com/inward/record.url?scp=0022225394&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022225394&partnerID=8YFLogxK

U2 - 10.1159/000138132

DO - 10.1159/000138132

M3 - Article

C2 - 2999840

AN - SCOPUS:0022225394

VL - 31

SP - 278

EP - 283

JO - Pharmacology

JF - Pharmacology

SN - 0031-7012

IS - 5

ER -